𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor expression of Fas ligand (CD95L) and the consequences

✍ Scribed by Paul R Walker; Philippe Saas; Pierre-Yves Dietrich


Book ID
104358945
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
795 KB
Volume
10
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

✦ Synopsis


Tumors of diverse origin have recently been shown to express CD95 ligand and to induce apoptosis in CD95-expressing targets in vitro; however, in vivo, enhanced tumor growth and rejection have both been observed as a consequence of either immunosuppressive or proinflammatory functions of CD95 ligand. The final in vivo outcome of CD95 ligand expression will depend upon a complex balance of interactions relevant for each tumor in its particular microenvironment.


πŸ“œ SIMILAR VOLUMES


Identification of the ligand binding sit
✍ JΓΌrgen Bajorath πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 472 KB πŸ‘ 2 views

Fas (CD95), a member of the tumor necrosis factor receptor superfamily, and its ligand (FasL), a tumor necrosis factor-like protein, are intensely studied because their interaction on the cell surface is critical for the induction of programmed cell death (apoptosis) and the regulation of immune res